Furthermore, leucine-rich repeat kinase 2 (LRRK2) and myocyte enhancer factor 2D (MEF2D) have been identified as typical CMA substrates in neurodegenerative diseases [52, 53]. Here, LRRK2 is linked to neurodegenerative disease.